StonvexLoading…
StonvexStonvexStonvexCore line items from CLGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.37M | $515.00K | $10.96M | $299.00K |
Operating Income | $-11.48M | $-17.25M | $-7.51M | $-17.10M |
Net Income | $-11.49M | $-16.61M | $-7.02M | $-16.93M |
EPS (Diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 |
Total Assets | $10.79M | $18.71M | $34.13M | $37.77M |
Total Liabilities | $4.70M | $5.25M | $5.79M | $5.49M |
Cash & Equivalents | $5.59M | $11.91M | $26.67M | $29.65M |
Free Cash Flow OCF − CapEx | $-9.45M | $-14.58M | $-3.72M | $-14.97M |
Shares Outstanding | 12.80M | 11.45M | 11.45M | 11.19M |